2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访

2016-06-30 国外内分泌相关专家小组(统称) Colomb Med (Cali). 2016 Jun 30;47(2):109-31.

在哥伦比亚,糖尿病史一个公共健康问题。本文主要内容包括了2型糖尿病的预防,早期识别,诊断,管理以及随访等内容。

中文标题:

2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访

英文标题:

Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults.

发布日期:

2016-06-30

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访)] GetToolGuiderByIdResponse(projectId=1, id=87f0a1c0012600ec, title=2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访, enTitle=Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults., guiderFrom=Colomb Med (Cali). 2016 Jun 30;47(2):109-31., authorId=null, author=, summary=在哥伦比亚,糖尿病史一个公共健康问题。本文主要内容包括了2型糖尿病的预防,早期识别,诊断,管理以及随访等内容。, cover=, journalId=null, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Thu Jun 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=本文主要内容包括了2型糖尿病的预防,早期识别,诊断,管理以及随访等内容。 <div><br> </div>拓展指南:<strong>与<font color="red">糖尿病</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=87f0a1c0012600ec" title="2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访" target="_blank">2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6a95b1c001252e4f" title="2016 内科应用利拉鲁肽治疗糖尿病专家共识" target="_blank">2016 内科应用利拉鲁肽治疗糖尿病专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f1ec1c0012ae637" title="2016 中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南" target="_blank">2016 中国成人2型糖尿病患者动脉粥样硬化性脑心血管疾病分级预防指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f405f1c001238547" title="2013 中国2型糖尿病防治指南(2013年版)" target="_blank">2013 中国2型糖尿病防治指南(2013年版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f8fa71c0012312d3" title="2016 2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)" target="_blank">2016 2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target="_blank">有关糖尿病更多指南</a><a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85" target="_blank"><ul><br></ul></a></ul>, tagList=[TagDto(tagId=2052, tagName=2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6584, appHits=390, showAppHits=0, pcHits=3896, showPcHits=2856, likes=153, shares=4, comments=4, approvalStatus=1, publishedTime=Wed Aug 24 13:17:04 CST 2016, publishedTimeString=2016-06-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Aug 24 13:17:04 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:11:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访)])
2016 临床实践指南:成人2型糖尿病患者的预防,早期识别,诊断,管理以及随访
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105158, encodeId=7073105158b5, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:44:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105159, encodeId=07ea10515979, content=继续跟进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:44:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 1e0f7307m29(暂无匿称)

    好好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105158, encodeId=7073105158b5, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:44:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105159, encodeId=07ea10515979, content=继续跟进, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:44:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 1e0f7307m29(暂无匿称)

    继续跟进

    0